Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Salmonella enterica subsp. houtenae serovar 45:g,z51:- strain:20-369

ABSTRACT: Salmonella enterica subsp. houtenae serovar 45:g,z51:- strain:20-369 Genome sequencing

PROVIDER: PRJNA725952 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Salmonella enterica subsp. enterica serovar Typhimurium strain:369

Project description:Salmonella enterica subsp. enterica serovar Typhimurium strain:369 Genome sequencing and assembly

| PRJNA615138 | ENA

Salmonella enterica subsp. houtenae serovar 16:z4,z32:-- str. RKS3027

Project description:Salmonella enterica subsp. houtenae serovar 16:z4,z32:-- str. RKS3027 Genome sequencing and assembly

| PRJNA176876 | ENA

Salmonella enterica subsp. houtenae strain:SA602

Project description:Salmonella enterica subsp. houtenae strain:SA602 Genome sequencing and assembly

| PRJNA492852 | ENA

Consotaella salsifontis strain:USBA 369 | isolate:CMPUJ U 369

Project description:Consotaella salsifontis strain:USBA 369 | isolate:CMPUJ U 369 Genome sequencing

| PRJNA329801 | ENA

Regulation of succinate signaling and immunometabolism in diabetes-associated atherosclerosis by miR-369-3p

Project description:Atherosclerosis is accelerated under diabetic conditions in part due to altered macrophage metabolism and function. Identifying critical factors to restore metabolic alterations and promote resolution of inflammation remains an unmet goal. MicroRNAs (miRs) orchestrate multiple signaling events in macrophages and regulate inflammation, yet their therapeutic potential in diabetes-associated atherosclerosis remains poorly understood. miRNA profiling of aortic intimal lesions from Ldlr-/- mice on a high-fat sucrose containing (HFSC) diet for 12 weeks revealed low expression of miR-369-3p. miR-369-3p was also reduced in peripheral blood mononuclear cells (PBMCs) from diabetic patients with coronary artery disease. Cell-type expression profiling showed miR-369-3p enrichment in aortic macrophages. Treatment with oxLDL reduced miR-369-3p expression in-stimulation mouse bone marrow-derived macrophages (BMDMs) downregulated miR-369-3p. Overexpression of miR-369-3p restored the oxLDL-mediated decrease of OXPHOS in BMDMs. Mechanistically, we found that miR-369-3p targeted the succinate receptor (GPR91) to alleviate the oxLDL-induced activation of inflammasome signaling pathways. Therapeutic administration of miR-369-3p in HFSC-fed Ldlr-/- mice reduced GPR91 expression in lesional macrophages and the diabetes-mediated accelerated atherosclerosis, evident by a decrease in plaque size and in the accumulation of pro-inflammatory Ly6Chi macrophages. RNA-seq analyses showed more pro-resolving pathways in plaque macrophages from miR-369-3p treated mice, consistent with an increase in macrophage efferocytosis in lesions. These findings establish a therapeutic role for miR-369-3p in halting diabetes-associated atherosclerosis by regulating GPR91 and macrophage succinate metabolism.

2024-12-04 | GSE244760 | GEO

Salmonella enterica subsp. enterica serovar Typhimurium strain:LSP 45/00

Project description:Salmonella enterica subsp. enterica serovar Typhimurium strain:LSP 45/00 Genome sequencing

| PRJNA380060 | ENA

Salmonella enterica subsp. houtenae serovar 16:z4,z32:-- strain:RKS3027 | isolate:not collected

Project description:Salmonella enterica subsp. houtenae serovar 16:z4,z32:-- strain:RKS3027 | isolate:not collected Genome sequencing

| PRJNA847875 | ENA

Variovorax sp. 369

Project description:Variovorax sp. 369 Genome sequencing and assembly

| PRJNA509336 | ENA

Salmonella enterica subsp. houtenae str. ATCC BAA-1581

Project description:Salmonella enterica subsp. houtenae str. ATCC BAA-1581 Genome sequencing and assembly